LMO2 was highly and homogenously expressed across all leukemia populations, but also in monocytes and dendritic cells and the majority of CD34+ cells, even before GT (Supplementary Fig. 6e), making it an unreliable transcriptional marker to distinguish the leukemic clone from non-malignant progenitors. Here, CD34 is linked to leukemia.